Castle Biosciences, Inc. (CSTL) vs Latigo Biotherapeutics Inc. (LTGO)

A side-by-side comparison of Castle Biosciences, Inc. and Latigo Biotherapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CSTL

Castle Biosciences, Inc.

$1.02B

$33.36HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

LTGO

Latigo Biotherapeutics Inc.

$978M

$16.26HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CSTL vs LTGO

growth of $100 · dividends reinvested · last 1y

CSTL +20.6% (+20.6%/yr)LTGO -7.6% (-7.6%/yr)CSTL compounded faster over this window

CSTL LTGO

Metrics side by side

Total return (annualized)

Metric	CSTL	LTGO
Total return (1Y)	60.94%	N/A
Total return CAGR (3Y)	35.10%	N/A
Total return CAGR (5Y)	-10.28%	N/A

LTGO is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full CSTL analysis Full LTGO analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.